The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer
NCT05411809
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Stereotactic Body Radiation Therapy
Interventions
DRUG:
drug adjuvant therapy
Sponsor
Peking University Third Hospital